[Thrombolytic therapy of antithrombin III-deficiency-induced mesenteric vein thrombosis in a newly operated patient].
A 21-year-old patient presented with extensive thrombosis of the mesenteric veins. He was in a serious condition after laparatomy in another hospital. The cause of the thrombotic event was found to be an inherited antithrombin III-deficiency. As a sole therapeutic possibility a systemic lysis with streptokinase was performed and was followed by a favourable immediate result. Unfortunately the subsequent course was complicated by a histologically confirmed necrotizing arteritis which was responsible for the lethal outcome 57 days after admission.
Bickelhaupt
A
A
Allgemeinchirurgische Klinik, Klinik am Eichert Göppingen.
Jehle
M
M
Eisele
R
R
D000328:Adult; D000990:Antithrombin III / Q000008:administration & dosage; D020152:Antithrombin III Deficiency; D001062:Appendectomy; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D008641:Mesenteric Vascular Occlusion / Q000188:drug therapy*; D008642:Mesenteric Veins / Q000187:drug effects; D011183:Postoperative Complications / Q000188:drug therapy*; D013300:Streptokinase / Q000008:administration & dosage*; D013927:Thrombosis / Q000188:drug therapy*
D000990:Antithrombin III; D013300:Streptokinase